SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S.E. Cremer, G.E. Singletary, L.H. Olsen, K. Wallace, J. Häggström, I. Ljungvall, K. Höglund, C.A. Reynolds, N. Pizzinat, M.A. Oyama, Serotonin Concentrations in Platelets, Plasma, Mitral Valve Leaflet, and Left Ventricular Myocardial Tissue in Dogs with Myxomatous Mitral Valve Disease, Journal of Veterinary Internal Medicine, 2014, 28, 4
  2. 2
    S.E. Cremer, N.E. Zois, S.G. Moesgaard, N. Ravn, S. Cirera, J.L. Honge, M.H. Smerup, J.M. Hasenkam, E. Sloth, P.S. Leifsson, T. Falk, M.A. Oyama, C. Orton, T. Martinussen, L.H. Olsen, Strong association between activated valvular interstitial cells and histopathological lesions in porcine model of induced mitral regurgitation, International Journal of Cardiology, 2014, 174, 2, 443

    CrossRef

  3. 3
    Sonja Fonfara, Udo Hetzel, Mark A. Oyama, Anja Kipar, The potential role of myocardial serotonin receptor 2B expression in canine dilated cardiomyopathy, The Veterinary Journal, 2014, 199, 3, 406

    CrossRef

  4. 4
    Bram Roosens, Gezim Bala, Steven Droogmans, Guy Van Camp, Joke Breyne, Bernard Cosyns, Animal models of organic heart valve disease, International Journal of Cardiology, 2013, 165, 3, 398

    CrossRef

  5. 5
    Luigi Michele Pavone, Russell A. Norris, Distinct Signaling Pathways Activated by “Extracellular” and “Intracellular” Serotonin in Heart Valve Development and Disease, Cell Biochemistry and Biophysics, 2013, 67, 3, 819

    CrossRef

  6. 6
    I. Ljungvall, K. Höglund, I. Lilliehöök, M.A. Oyama, A. Tidholm, H. Tvedten, J. Häggström, Serum Serotonin Concentration Is Associated with Severity of Myxomatous Mitral Valve Disease in Dogs, Journal of Veterinary Internal Medicine, 2013, 27, 5
  7. 7
    Dennis J. Trafny, Lisa M. Freeman, Barret J. Bulmer, John M. MacGregor, John E. Rush, Kathryn M. Meurs, Mark A. Oyama, Auscultatory, echocardiographic, biochemical, nutritional, and environmental characteristics of mitral valve disease in Norfolk terriers, Journal of Veterinary Cardiology, 2012, 14, 1, 261

    CrossRef

  8. 8
    Magdalena Łój, Magdalena Garncarz, Michał Jank, Genomic and genetic aspects of heart failure in dogs — A review, Acta Veterinaria Hungarica, 2012, 60, 1, 17

    CrossRef

  9. 9
    Clarke E. Atkins, Jens Häggström, Pharmacologic management of myxomatous mitral valve disease in dogs, Journal of Veterinary Cardiology, 2012, 14, 1, 165

    CrossRef

  10. 10
    E. Christopher Orton, Carla M.R. Lacerda, Holly B. MacLea, Signaling pathways in mitral valve degeneration, Journal of Veterinary Cardiology, 2012, 14, 1, 7

    CrossRef

  11. 11
    Aurélie Lardeux, Florence Kyndt, Simon Lecointe, Hervé Le Marec, Jean Merot, Jean-Jacques Schott, Thierry Le Tourneau, Vincent Probst, Filamin-A-Related Myxomatous Mitral Valve Dystrophy: Genetic, Echocardiographic and Functional Aspects, Journal of Cardiovascular Translational Research, 2011, 4, 6, 748

    CrossRef

  12. 12
    Sarah M. Scruggs, Sirilak Disatian, E. Christopher Orton, Serotonin transmembrane transporter is down-regulated in late-stage canine degenerative mitral valve disease, Journal of Veterinary Cardiology, 2010, 12, 3, 163

    CrossRef